These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8675969)

  • 1. Naltrexone use in the treatment of anorexia nervosa and bulimia nervosa.
    Marrazzi MA; Bacon JP; Kinzie J; Luby ED
    Int Clin Psychopharmacol; 1995 Sep; 10(3):163-72. PubMed ID: 8675969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An experimental protocol for a double-blind placebo-controlled evaluation of the effectiveness of oral naltrexone in management of adolescent eating disorders.
    Roden RC; Billman M; Lane-Loney S; Essayli J; Mahr F; Vrana K; Ryan S
    Contemp Clin Trials; 2022 Nov; 122():106937. PubMed ID: 36167287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.
    Kennedy SH; Goldbloom DS
    Drugs; 1991 Mar; 41(3):367-77. PubMed ID: 1711444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binge eating disorder: response to naltrexone.
    Marrazzi MA; Markham KM; Kinzie J; Luby ED
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):143-5. PubMed ID: 7735342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug treatment of anorexia nervosa and bulimia nervosa. A review].
    Fichter MM
    Nervenarzt; 1993 Jan; 64(1):21-35. PubMed ID: 8437645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose naltrexone and liver function safety.
    Marrazzi MA; Wroblewski JM; Kinzie J; Luby ED
    Am J Addict; 1997; 6(1):21-9. PubMed ID: 9097868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are psychotropic drugs necessary for the treatment of anorexia and bulimia nervosa?].
    Thiel A
    Psychother Psychosom Med Psychol; 1997; 47(9-10):332-45. PubMed ID: 9411463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia.
    Marrazzi MA; Kinzie J; Luby ED
    Int Clin Psychopharmacol; 1995 Sep; 10(3):173-6. PubMed ID: 8675970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 1: improvement in binge and purge measures.
    Hoopes SP; Reimherr FW; Hedges DW; Rosenthal NR; Kamin M; Karim R; Capece JA; Karvois D
    J Clin Psychiatry; 2003 Nov; 64(11):1335-41. PubMed ID: 14658948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bulimic disorders in anorexia nervosa].
    Korkina MV; Tsivil'ko MA; Marilov VV; Kareva MA; Kislova EK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):43-7. PubMed ID: 1654701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of a prior history of anorexia in bulimia nervosa.
    Sullivan PF; Bulik CM; Carter FA; Gendall KA; Joyce PR
    Int J Eat Disord; 1996 Nov; 20(3):253-61. PubMed ID: 8912037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the opiate antagonist, naltrexone, on binging antecedents and plasma beta-endorphin concentrations.
    Chatoor I; Herman BH; Hartzler J
    J Am Acad Child Adolesc Psychiatry; 1994 Jun; 33(5):748-52. PubMed ID: 8056738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pimozide in the treatment of psychogenic eating disorders].
    Faltus F
    Cesk Psychiatr; 1993 Jan; 89(1):24-6. PubMed ID: 8508461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enlargement of the parotid glands in bulimia nervosa and anorexia nervosa].
    Rzeczycki P; Filipowski M
    Otolaryngol Pol; 1996; 50(3):318-20. PubMed ID: 9045172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants versus placebo for people with bulimia nervosa.
    Bacaltchuk J; Hay P
    Cochrane Database Syst Rev; 2003; (4):CD003391. PubMed ID: 14583971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled, double-blind crossover study of naltrexone hydrochloride in outpatients with normal weight bulimia.
    Mitchell JE; Christenson G; Jennings J; Huber M; Thomas B; Pomeroy C; Morley J
    J Clin Psychopharmacol; 1989 Apr; 9(2):94-7. PubMed ID: 2656781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of bulimic and non-bulimic anorexia nervosa patients during treatment.
    Eckert ED; Halmi KA; Marchi P; Cohen J
    Psychol Med; 1987 Nov; 17(4):891-8. PubMed ID: 3432463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open trial of fluoxetine in patients with anorexia nervosa.
    Kaye WH; Weltzin TE; Hsu LK; Bulik CM
    J Clin Psychiatry; 1991 Nov; 52(11):464-71. PubMed ID: 1744064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subgroups of anorexia nervosa and bulimia: validity and utility.
    Mickalide AD; Andersen AE
    J Psychiatr Res; 1985; 19(2-3):121-8. PubMed ID: 3862826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.